Cargando…

Resveratrol Improves Heart Function by Moderating Inflammatory Processes in Patients with Systolic Heart Failure

The effects of resveratrol (RES) in heart failure have already been evaluated in animal models; however, in human clinical trials, they have not been confirmed yet. The aim of this study was to assess the effects of resveratrol treatment in systolic heart failure patients (heart failure with reduced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gal, Roland, Deres, Laszlo, Horvath, Orsolya, Eros, Krisztian, Sandor, Barbara, Urban, Peter, Soos, Szilvia, Marton, Zsolt, Sumegi, Balazs, Toth, Kalman, Habon, Tamas, Halmosi, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696241/ https://www.ncbi.nlm.nih.gov/pubmed/33187089 http://dx.doi.org/10.3390/antiox9111108

Ejemplares similares

Cardioprotective Effect of Resveratrol in a Postinfarction Heart Failure Model
por: Riba, Adam, et al.
Publicado: (2017)

The Effect of Resveratrol on the Cardiovascular System from Molecular Mechanisms to Clinical Results
por: Gal, Roland, et al.
Publicado: (2021)

The Effects of Bradykinin B1 Receptor Antagonism on the Myocardial and Vascular Consequences of Hypertension in SHR Rats
por: Deres, Laszlo, et al.
Publicado: (2019)

Doxycycline protects against ROS-induced mitochondrial fragmentation and ISO-induced heart failure
por: Riba, Adam, et al.
Publicado: (2017)

BGP-15 Protects against Heart Failure by Enhanced Mitochondrial Biogenesis and Decreased Fibrotic Remodelling in Spontaneously Hypertensive Rats
por: Horvath, Orsolya, et al.
Publicado: (2021)

Hemorheological Alterations in Patients with Heart Failure with Reduced Ejection Fraction Treated by Resveratrol
por: Gal, Roland, et al.
Publicado: (2020)

Chronic PARP-1 inhibition reduces carotid vessel remodeling and oxidative damage of the dorsal hippocampus in spontaneously hypertensive rats
por: Eros, Krisztian, et al.
Publicado: (2017)

PARP-Inhibitor Treatment Prevents Hypertension Induced Cardiac Remodeling by Favorable Modulation of Heat Shock Proteins, Akt-1/GSK-3β and Several PKC Isoforms
por: Deres, Laszlo, et al.
Publicado: (2014)

Modulation of Mitochondrial Quality Control Processes by BGP-15 in Oxidative Stress Scenarios: From Cell Culture to Heart Failure
por: Horvath, Orsolya, et al.
Publicado: (2021)

Resveratrol and beyond: The Effect of Natural Polyphenols on the Cardiovascular System: A Narrative Review
por: Gál, Roland, et al.
Publicado: (2023)

Surgical treatment of heart failure due to giant coronary artery fistula: a case report
por: Sandor, Barbara, et al.
Publicado: (2020)

Pre-Treatment with Statins for Coronary Intervention: Pleiotropy of Statins or Effect of LDL-cholesterol Reduction?
por: Habon, Tamas, et al.
Publicado: (2016)

Substance Use-Associated Mortality among Heart Donors after the COVID-19 National Emergency Increased but Did Not Affect Peri-Transplant Outcomes
por: Fraser, Meg, et al.
Publicado: (2023)

l-arginine, asymmetric and symmetric dimethylarginine for early outcome prediction in unselected cardiac arrest victims: a prospective cohort study
por: Csiszar, Beata, et al.
Publicado: (2021)

Novel insights into the athlete’s heart: is myocardial work the new champion of systolic function?
por: Tokodi, Márton, et al.
Publicado: (2021)

Cyclophilin D‐dependent mitochondrial permeability transition amplifies inflammatory reprogramming in endotoxemia
por: Veres, Balazs, et al.
Publicado: (2021)

PARP Inhibitor PJ34 Protects Mitochondria and Induces DNA-Damage Mediated Apoptosis in Combination With Cisplatin or Temozolomide in B16F10 Melanoma Cells
por: Cseh, Anna Maria, et al.
Publicado: (2019)

Advances in systolic heart failure
por: Yuzefpolskaya, Melana, et al.
Publicado: (2010)

Antioxidant and Anti-Inflammatory Effects in RAW264.7 Macrophages of Malvidin, a Major Red Wine Polyphenol
por: Bognar, Eszter, et al.
Publicado: (2013)

Echocardiographic evaluation of systolic heart failure
por: Lo, Queenie, et al.
Publicado: (2015)

How to consider target heart rate in patients with systolic heart failure
por: Izumida, Toshihide, et al.
Publicado: (2020)

Lineage diversification, homo- and heterologous reassortment and recombination shape the evolution of chicken orthoreoviruses
por: Farkas, Szilvia L., et al.
Publicado: (2016)

Systolic pulmonary regurgitation affects the outcome of patients with severe systolic heart failure
por: Hsiao, Shih‐Hung, et al.
Publicado: (2021)

Modeling Pathologies of Diastolic and Systolic Heart Failure
por: Genet, M., et al.
Publicado: (2015)

Arrhythmias and Electrocardiographic Changes in Systolic Heart Failure
por: Devkota, Ashok, et al.
Publicado: (2016)

Pharmacological preconditioning with gemfibrozil preserves cardiac function after heart transplantation
por: Benke, Kálmán, et al.
Publicado: (2017)

Prognostic value of systolic short-term blood pressure variability in systolic heart failure
por: Berry, Matthieu, et al.
Publicado: (2016)

Effect of Visit‐to‐Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the I (f) Inhibitor Ivabradine Trial (SHIFT) Trial
por: Böhm, Michael, et al.
Publicado: (2016)

The role of microRNAs in congenital heart disease
por: Nagy, Orsolya, et al.
Publicado: (2019)

Inflammasome activation in end‐stage heart failure‐associated atrial fibrillation
por: Kugler, Szilvia, et al.
Publicado: (2022)

Comparison of Genetic Susceptibility to Coronary Heart Disease in the Hungarian Populations: Risk Prediction Models for Coronary Heart Disease
por: Nasr, Nayla, et al.
Publicado: (2023)

Association between Obesity and Overweight and Cardiorespiratory and Muscle Performance in Adolescents
por: Petrovics, Peter, et al.
Publicado: (2020)

Effects of Moderate Aerobic Exercise Training on Hemorheological and Laboratory Parameters in Ischemic Heart Disease Patients
por: Sandor, Barbara, et al.
Publicado: (2014)

Gout and the risk for incident heart failure and systolic dysfunction
por: Krishnan, Eswar
Publicado: (2012)

Novel Strategies for the Detection of Systolic and Diastolic Heart Failure
por: Bolt, Cara Lodewijks-vd, et al.
Publicado: (2009)

Use of Inotropic Agents in Treatment of Systolic Heart Failure
por: Tariq, Sohaib, et al.
Publicado: (2015)

Right ventricular systolic function in hypertensive heart failure
por: Oketona, OA, et al.
Publicado: (2017)

Genetics and genomics of dilated cardiomyopathy and systolic heart failure
por: Tayal, Upasana, et al.
Publicado: (2017)

Salivary Protein Panel to Diagnose Systolic Heart Failure
por: Zhang, Xi, et al.
Publicado: (2019)

Cardiac Amyloidosis Presenting as Biventricular Systolic Heart Failure
por: Oye, Monique, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e7573r6v7jfalg2p551of5mecu